BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 22665224)

  • 1. Increased pro-inflammatory cytokine production after lipopolysaccharide stimulation in patients with X-linked agammaglobulinemia.
    González-Serrano ME; Estrada-García I; Mogica-Martínez D; González-Garay A; López-Herrera G; Berrón-Ruiz L; Espinosa-Padilla SE; Yamazaki-Nakashimada MA; Vargas-Hernández A; Santos-Argumedo L; Estrada-Parra SA; Espinosa-Rosales FJ
    J Clin Immunol; 2012 Oct; 32(5):967-74. PubMed ID: 22665224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toll-like receptor 4-, 7-, and 8-activated myeloid cells from patients with X-linked agammaglobulinemia produce enhanced inflammatory cytokines.
    Marron TU; Martinez-Gallo M; Yu JE; Cunningham-Rundles C
    J Allergy Clin Immunol; 2012 Jan; 129(1):184-90.e1-4. PubMed ID: 22088613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toll-like receptor signaling is impaired in dendritic cells from patients with X-linked agammaglobulinemia.
    Taneichi H; Kanegane H; Sira MM; Futatani T; Agematsu K; Sako M; Kaneko H; Kondo N; Kaisho T; Miyawaki T
    Clin Immunol; 2008 Feb; 126(2):148-54. PubMed ID: 18271077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The lack of BTK does not impair monocytes and polymorphonuclear cells functions in X-linked agammaglobulinemia under treatment with intravenous immunoglobulin replacement.
    Cavaliere FM; Prezzo A; Bilotta C; Iacobini M; Quinti I
    PLoS One; 2017; 12(4):e0175961. PubMed ID: 28422989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disturbed Transcription of TLRs' Negative Regulators and Cytokines Secretion among TLR4- and 9-Activated PBMCs of Agammaglobulinemic Patients.
    Sanaei R; Rezaei N; Aghamohammadi A; Delbandi AA; Tavasolian P; Tajik N
    Immunol Invest; 2019 Nov; 48(8):860-874. PubMed ID: 31185757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TLR signaling and effector functions are intact in XLA neutrophils.
    Marron TU; Rohr K; Martinez-Gallo M; Yu J; Cunningham-Rundles C
    Clin Immunol; 2010 Oct; 137(1):74-80. PubMed ID: 20634142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bruton tyrosine kinase mediates TLR9-dependent human dendritic cell activation.
    Lougaris V; Baronio M; Vitali M; Tampella G; Cattalini M; Tassone L; Soresina A; Badolato R; Plebani A
    J Allergy Clin Immunol; 2014 Jun; 133(6):1644-50.e4. PubMed ID: 24612681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. X-linked agammaglobulinemia: Twenty years of single-center experience from North West India.
    Singh S; Rawat A; Suri D; Gupta A; Garg R; Saikia B; Minz RW; Sehgal S; Chan KW; Lau YL; Kamae C; Honma K; Nakagawa N; Imai K; Nonoyama S; Oshima K; Mitsuiki N; Ohara O
    Ann Allergy Asthma Immunol; 2016 Oct; 117(4):405-411. PubMed ID: 27593100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional analysis of peripheral blood B cells in patients with X-linked agammaglobulinemia.
    Nonoyama S; Tsukada S; Yamadori T; Miyawaki T; Jin YZ; Watanabe C; Morio T; Yata J; Ochs HD
    J Immunol; 1998 Oct; 161(8):3925-9. PubMed ID: 9780159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. X-Linked Agammagobulinemia in a Large Series of North African Patients: Frequency, Clinical Features and Novel BTK Mutations.
    Aadam Z; Kechout N; Barakat A; Chan KW; Ben-Ali M; Ben-Mustapha I; Zidi F; Ailal F; Attal N; Doudou F; Abbadi MC; Kaddache C; Smati L; Touri N; Chemli J; Gargah T; Brini I; Bakhchane A; Charoute H; Jeddane L; El Atiqi S; El Hafidi N; Hida M; Saile R; Alj HS; Boukari R; Bejaoui M; Najib J; Barbouche MR; Lau YL; Mellouli F; Bousfiha AA
    J Clin Immunol; 2016 Apr; 36(3):187-94. PubMed ID: 26931785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toll-like receptors pathway in common variable immune deficiency (CVID) and X-linked agammaglobulinemia (XLA).
    Tavasolian P; Sharifi L; Aghamohammadi A; Noorbakhsh F; Sanaei R; Shabani M; Rezaei N
    Eur Cytokine Netw; 2018 Nov; 29(4):153-158. PubMed ID: 30698158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. X-linked agammaglobulinemia in a 10-year-old boy with a novel non-invariant splice-site mutation in Btk gene.
    Maekawa K; Yamada M; Okura Y; Sato Y; Yamada Y; Kawamura N; Ariga T
    Blood Cells Mol Dis; 2010 Apr; 44(4):300-4. PubMed ID: 20122858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bruton's tyrosine kinase is not essential for LPS-induced activation of human monocytes.
    Pérez de Diego R; López-Granados E; Pozo M; Rodríguez C; Sabina P; Ferreira A; Fontan G; García-Rodríguez MC; Alemany S
    J Allergy Clin Immunol; 2006 Jun; 117(6):1462-9. PubMed ID: 16751014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. De novo mutation in the BTK gene of atypical X-linked agammaglobulinemia in a patient with recurrent pyoderma.
    Lin MT; Chien YH; Shyur SD; Huang LH; Chiang YC; Wen DC; Liang PH; Yang HC
    Ann Allergy Asthma Immunol; 2006 May; 96(5):744-8. PubMed ID: 16729790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutation screening of the BTK gene in 56 families with X-linked agammaglobulinemia (XLA): 47 unique mutations without correlation to clinical course.
    Holinski-Feder E; Weiss M; Brandau O; Jedele KB; Nore B; Bäckesjö CM; Vihinen M; Hubbard SR; Belohradsky BH; Smith CI; Meindl A
    Pediatrics; 1998 Feb; 101(2):276-84. PubMed ID: 9445504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical characteristics and prenatal diagnosis for 22 families in Henan Province of China with X-linked agammaglobulinemia (XLA) related to Bruton's tyrosine kinase (BTK) gene mutations.
    Gao S; Hu S; Duan H; Wang L; Kong X
    BMC Med Genet; 2020 Jun; 21(1):131. PubMed ID: 32552675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bruton's tyrosine kinase is required for TLR2 and TLR4-induced TNF, but not IL-6, production.
    Horwood NJ; Page TH; McDaid JP; Palmer CD; Campbell J; Mahon T; Brennan FM; Webster D; Foxwell BM
    J Immunol; 2006 Mar; 176(6):3635-41. PubMed ID: 16517732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and Genetic Study of X-linked Agammaglobulinemia Patients (The Benefit of Early Diagnosis).
    Alizadeh Z; Dashti P; Mazinani M; Nourizadeh M; Shakerian L; Tajik S; Movahedi M; Mamishi S; Pourpak Z; Fazlollahi MR
    Iran J Allergy Asthma Immunol; 2020 Jun; 19(3):305-309. PubMed ID: 32615664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delayed diagnosis in X-linked agammaglobulinemia and its relationship to the occurrence of mutations in BTK non-kinase domains.
    Carrillo-Tapia E; García-García E; Herrera-González NE; Yamazaki-Nakashimada MA; Staines-Boone AT; Segura-Mendez NH; Scheffler-Mendoza SC; O Farrill-Romanillos P; Gonzalez-Serrano ME; Rodriguez-Alba JC; Santos-Argumedo L; Berron-Ruiz L; Sanchez-Flores A; López-Herrera G
    Expert Rev Clin Immunol; 2018 Jan; 14(1):83-93. PubMed ID: 29202590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Importance of B cell co-stimulation in CD4(+) T cell differentiation: X-linked agammaglobulinaemia, a human model.
    Martini H; Enright V; Perro M; Workman S; Birmelin J; Giorda E; Quinti I; Lougaris V; Baronio M; Warnatz K; Grimbacher B
    Clin Exp Immunol; 2011 Jun; 164(3):381-7. PubMed ID: 21488866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.